Morningstar® Stock Report™

Rhoen Klinikum AG RHK

Gewinnmarge (% des Umsatzes)
20192020202120222023
Ertrag100,00%100,00%100,00%100,00%100,00%
Betriebskosten31,28%31,06%30,70%30,88%33,37%
Bruttogewinn68,72%68,94%69,30%69,12%66,63%
Vertriebsgemeinkosten1,86%1,78%1,44%1,50%4,80%
Forschung und Entwicklung-----
Umsatzrendite4,21%0,72%1,39%2,38%2,69%
Net Int, Inc and Other8,37%1,00%3,34%4,71%5,95%
EBIT Marge4,16%0,29%1,95%2,33%3,26%
Ertragskraft
20192020202120222023
Steuersatz0,75%0,11%-0,20%0,46%0,52%
Nettomarge3,32%0,11%2,02%1,74%2,64%
Gesamtkapitalrendite2,690,091,721,492,23
Financial Leverage1,411,401,391,391,41
Eigenkapitalsrendite3,770,122,392,083,13